{"id":"https://openalex.org/W4282960396","doi":"https://doi.org/10.1158/1538-7445.am2022-5314","title":"Abstract 5314: Selinexor, a selective inhibitor of nuclear export (SINE) compound, enhances the anti-tumor activity of Eribulin in leiomyosarcoma","display_name":"Abstract 5314: Selinexor, a selective inhibitor of nuclear export (SINE) compound, enhances the anti-tumor activity of Eribulin in leiomyosarcoma","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282960396","doi":"https://doi.org/10.1158/1538-7445.am2022-5314"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-5314","doi":"https://doi.org/10.1158/1538-7445.am2022-5314","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-5314","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101566451","display_name":"Sonam Mittal","orcid":"https://orcid.org/0000-0002-2268-2319","observed_orcids":["https://orcid.org/0000-0002-2268-2319"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sonam Mittal","raw_affiliation_strings":["1The Medical College of Wisconsin, Milwaukee, WI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Medical College of Wisconsin, Milwaukee, WI;","institution_ids":["https://openalex.org/I204308271"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044506702","display_name":"Ishaque Pulikkal Kadamberi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ishaque Pulikkal","raw_affiliation_strings":["1The Medical College of Wisconsin, Milwaukee, WI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Medical College of Wisconsin, Milwaukee, WI;","institution_ids":["https://openalex.org/I204308271"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100308724","display_name":"Hua Chang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152529","display_name":"Karyopharm Therapeutics (United States)","ror":"https://ror.org/04ty78924","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152529"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hua Chang","raw_affiliation_strings":["2Karyopharm, Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Karyopharm, Newton, MA","institution_ids":["https://openalex.org/I4210152529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057755017","display_name":"Yosef Landesman","orcid":"https://orcid.org/0000-0001-5542-5098","observed_orcids":["https://orcid.org/0000-0001-5542-5098"]},"institutions":[{"id":"https://openalex.org/I4210152529","display_name":"Karyopharm Therapeutics (United States)","ror":"https://ror.org/04ty78924","country_code":"US","type":"company","lineage":["https://openalex.org/I4210152529"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yosef Landesman","raw_affiliation_strings":["2Karyopharm, Newton, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Karyopharm, Newton, MA","institution_ids":["https://openalex.org/I4210152529"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082268894","display_name":"John A. Charlson","orcid":"https://orcid.org/0000-0003-2426-0029","observed_orcids":["https://orcid.org/0000-0003-2426-0029"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Charlson","raw_affiliation_strings":["1The Medical College of Wisconsin, Milwaukee, WI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Medical College of Wisconsin, Milwaukee, WI;","institution_ids":["https://openalex.org/I204308271"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043392987","display_name":"Sunila Pradeep","orcid":"https://orcid.org/0000-0003-2441-7727","observed_orcids":["https://orcid.org/0000-0003-2441-7727"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sunila Pradeep","raw_affiliation_strings":["1The Medical College of Wisconsin, Milwaukee, WI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1The Medical College of Wisconsin, Milwaukee, WI;","institution_ids":["https://openalex.org/I204308271"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"5314","last_page":"5314"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.7768999934196472,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.7768999934196472,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11841","display_name":"Nuclear Structure and Function","score":0.13169999420642853,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selinexor","display_name":"selinexor","score":0.9879999756813049},{"id":"https://openalex.org/keywords/eribulin","display_name":"eribulin","score":0.7760000228881836},{"id":"https://openalex.org/keywords/leiomyosarcoma","display_name":"leiomyosarcoma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/soft-tissue-sarcoma","display_name":"soft tissue sarcoma","score":0.8809999823570251},{"id":"https://openalex.org/keywords/selective-inhibitor-of-nuclear-export","display_name":"selective inhibitor of nuclear export","score":0.8849999904632568},{"id":"https://openalex.org/keywords/xpo1","display_name":"CRM1","score":0.8960000276565552},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8029999732971191},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.7260000109672546},{"id":"https://openalex.org/keywords/xenograft-tumor-growth-inhibition","display_name":"xenograft tumor growth inhibition","score":0.8140000104904175},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.781000018119812},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.6129999756813049},{"id":"https://openalex.org/keywords/pazopanib","display_name":"pazopanib","score":0.7450000047683716},{"id":"https://openalex.org/keywords/dacarbazine","display_name":"dacarbazine","score":0.890999972820282},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9900000095367432}],"concepts":[{"id":"https://openalex.org/C2776387010","wikidata":"https://www.wikidata.org/wiki/Q408717","display_name":"Eribulin","level":5,"score":0.8972257375717163},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6353980898857117},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5768564939498901},{"id":"https://openalex.org/C2780752271","wikidata":"https://www.wikidata.org/wiki/Q2637746","display_name":"Trabectedin","level":4,"score":0.5256208777427673},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.509982705116272},{"id":"https://openalex.org/C2777532014","wikidata":"https://www.wikidata.org/wiki/Q1504713","display_name":"Leiomyosarcoma","level":2,"score":0.4941087067127228},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42909687757492065},{"id":"https://openalex.org/C2778629024","wikidata":"https://www.wikidata.org/wiki/Q720020","display_name":"Soft tissue sarcoma","level":3,"score":0.41538766026496887},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39559993147850037},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.3630911707878113},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3289757966995239},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.31564491987228394},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21625682711601257},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.20506387948989868},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.19702932238578796},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1765744984149933}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-5314","doi":"https://doi.org/10.1158/1538-7445.am2022-5314","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-5314","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4386774872","https://openalex.org/W6902280782","https://openalex.org/W4240535532","https://openalex.org/W3119297022","https://openalex.org/W2901041319","https://openalex.org/W2977685255","https://openalex.org/W2253821251","https://openalex.org/W4379346262","https://openalex.org/W4377861157","https://openalex.org/W4286312117"],"abstract_inverted_index":{"Abstract":[0],"Leiomyosarcoma":[1],"(LMS)":[2],"is":[3,32,55,100],"a":[4,42,56,262],"rare":[5],"soft":[6],"tissue":[7,15],"sarcoma":[8],"(STS)":[9],"that":[10,65],"begins":[11],"in":[12,20,93,102,125,135,182,189,194,210,232,276],"smooth":[13],"muscle":[14],"and":[16,40,47,76,82,99,105,133,154,160,173,177,201],"most":[17],"often":[18],"initiates":[19],"the":[21,78,121,148,170,195,244,271,282],"abdomen":[22],"or":[23],"uterus.":[24],"Compared":[25],"with":[26,37,127,158,165,199,215,220,223],"other":[27],"uterine":[28,30],"cancers,":[29],"LMS":[31,136,149],"an":[33],"aggressive":[34],"tumor":[35,73,229],"associated":[36],"poor":[38],"prognosis":[39],"has":[41,89],"high":[43],"risk":[44],"of":[45,50,60,80,123,175,197,205,240,265,274,281],"recurrence":[46],"death,":[48],"regardless":[49],"stage":[51],"at":[52,243],"presentation.":[53],"Selinexor":[54,88,124,159,198,221],"first-in-class":[57],"selective":[58,263],"inhibitor":[59,264],"nuclear":[61,266],"export":[62,267],"(SINE)":[63,268],"compound":[64],"binds":[66],"covalently":[67],"to":[68],"exportin":[69],"1,":[70],"thereby":[71],"reactivating":[72],"suppressor":[74],"proteins":[75],"downregulating":[77],"expression":[79],"oncogenes":[81],"DNA":[83],"damage":[84],"repair":[85],"(DDR)":[86],"proteins.":[87],"demonstrated":[90],"preclinical":[91],"activity":[92,273],"various":[94],"cancer":[95],"types,":[96],"including":[97],"STS,":[98],"currently":[101],"Phase":[103],"I":[104],"II":[106],"clinical":[107,245],"trials":[108],"for":[109,285],"advanced":[110],"cancers":[111],"(Marretta":[112],"et":[113],"al.":[114],"2021).":[115],"In":[116],"this":[117,185],"study,":[118],"we":[119],"evaluated":[120,145,209],"effects":[122,140,204,227],"combination":[126,196],"Dacarbazine,":[128],"Gemcitabine,":[129],"Doxorubicin,":[130],"Pazopanib,":[131],"Eribulin,":[132],"Trabectedin":[134],"cell":[137,142,150,171,179,217],"lines.":[138,218],"The":[139,203],"on":[141,228],"viability":[143],"were":[144,207],"by":[146],"treating":[147],"lines":[151,180],"SK-UT1":[152,176,190,216,233],"(p53-mut)":[153],"SK-UT1-B":[155,178],"(p53":[156],"WT)":[157],"different":[161],"chemotherapy":[162],"combinations.":[163],"Treatment":[164,219],"these":[166,241],"drugs":[167],"significantly":[168],"decreased":[169],"proliferation":[172],"survival":[174],"tested":[181],"vitro.":[183],"However,":[184],"effect":[186],"was":[187],"enhanced":[188],"cells":[191],"following":[192],"treatment":[193,206],"Eribulin":[200,224,275],"Doxorubicin.":[202],"also":[208],"mouse":[211],"xenograft":[212],"models":[213],"generated":[214],"combined":[222],"showed":[225],"synergistic":[226],"growth":[230],"inhibition":[231],"derived":[234],"xenografts":[235],"which":[236],"warrant":[237],"further":[238],"investigation":[239],"combinations":[242],"level.":[246],"Citation":[247],"Format:":[248],"Sonam":[249],"Mittal,":[250],"Ishaque":[251],"Pulikkal,":[252],"Hua":[253],"Chang,":[254],"Yosef":[255],"Landesman,":[256],"John":[257],"Charlson,":[258],"Sunila":[259],"Pradeep.":[260],"Selinexor,":[261],"compound,":[269],"enhances":[270],"anti-tumor":[272],"leiomyosarcoma":[277],"[abstract].":[278],"In:":[279],"Proceedings":[280],"American":[283],"Association":[284],"Cancer":[286,297],"Research":[287],"Annual":[288],"Meeting":[289],"2022;":[290],"2022":[291],"Apr":[292],"8-13.":[293],"Philadelphia":[294],"(PA):":[295],"AACR;":[296],"Res":[298],"2022;82(12_Suppl):Abstract":[299],"nr":[300],"5314.":[301]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2022-06-17T00:00:00"}